Yaky Yanay - CEO & President, Pluristem Therapeutics Inc

As of September 10, 2020


Yaky Yanay Net Worth

  • Net worth is estimated to be at least $2.94M
  • Owns at least 4,319,544 units of Pluristem Therapeutics Inc stock
  • Sold an estimated value of $586.76K in the last 13 years at Pluristem Therapeutics Inc

Yaky Yanay Compensation at Pluristem Therapeutics Inc in 2020

  • Earned a $320,911 salary
  • Received a total compensation of $350,377

Yaky Yanay Trading

  • Largest purchase of shares was 71,429 units , worth over $50K on April 8, 2019
  • Largest sale of shares was 69,850 units , worth over $299.98K on January 14, 2014
  • In total has made about 35 transactions over 13 years
  • Usually trades in December, with the busiest year in 2014
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Yaky Yanay Mailing Address

  • Mailing address is Argaman 14 Shimshit L3 17906 Israel

Pluristem Therapeutics Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Other Compensation
Total
Zami Aberman 2020 $439,704 - $61,540 $501,244
Zami Aberman 2019 $551,137 $478,500 $66,857 $1,096,494
Yaky Yanay 2020 $320,911 - $29,466 $350,377
Yaky Yanay 2019 $396,632 $461,100 $29,253 $886,985
Chen Franco-Yehuda 2020 $179,229 - $28,461 $207,690
Chen Franco-Yehuda 2019 $78,889 $112,329 $13,599 $204,817
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1158780/000121390021020786/ea139144-def14a_pluristem.htm

Pluristem Therapeutics Inc Insider Trading

  • The most recent transaction was 80,616 units bought on February 14, 2022 by Zami Aberman worth over $145.11K
  • In the last 14 years, insiders at Pluristem Therapeutics Inc sold an estimated value of $7.29M and bought an estimated value of $14.34M
  • The most active traders are Zami Aberman, Director,  Yaky Yanay, CEO & President,  and Israel Ben-Yoram, Director
  • Insider trading is most common in December, with the busiest year in 2009

PAM TRANSPORTATION SERVICES INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1